Cargando…
Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients
BACKGROUND: Over time, the chance of cure after the diagnosis of breast cancer has been increasing, as a consequence of earlier diagnosis, improved diagnostic procedures and more effective treatment options. However, oncologists are concerned by the risk of long term treatment side effects, includin...
Autores principales: | Frères, Pierre, Bouznad, Nassim, Servais, Laurence, Josse, Claire, Wenric, Stéphane, Poncin, Aurélie, Thiry, Jérôme, Moonen, Marie, Oury, Cécile, Lancellotti, Patrizio, Bours, Vincent, Jerusalem, Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789542/ https://www.ncbi.nlm.nih.gov/pubmed/29378531 http://dx.doi.org/10.1186/s12885-018-4015-4 |
Ejemplares similares
-
MicroRNAs in Valvular Heart Diseases: Potential Role as Markers and Actors of Valvular and Cardiac Remodeling
por: Oury, Cécile, et al.
Publicado: (2016) -
Differences in plasma microRNA content impair microRNA-based signature for breast cancer diagnosis in cohorts recruited from heterogeneous environmental sites
por: Uyisenga, Jeanne P., et al.
Publicado: (2021) -
Circulating microRNA-based screening tool for breast cancer
por: Frères, Pierre, et al.
Publicado: (2015) -
Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment
por: Onesti, Concetta Elisa, et al.
Publicado: (2018) -
Immunity and Breast Cancer: Focus on Eosinophils
por: Poncin, Aurélie, et al.
Publicado: (2021)